Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NPS-2390: representative of a novel class of potent and selective group I mGluR antagonists

Nov. 9, 1998

In vitro and in vivo pharmacology of CP-465022 presented at neuroscience meeting

Nov. 9, 1998

Novel proteasome inhibitor effective in animal model of stroke

Nov. 9, 1998

Effects of new free radical scavenger MDL-100002 in embolic stroke

Nov. 9, 1998

Centrally selective nAChR ligand from R.J. Reynolds considered Alzheimer's disease candidate

Nov. 9, 1998

Selective M2 receptor antagonist from Schering-Plough with potential in AD

Nov. 9, 1998

Novel 5-HT1B receptor antagonist presented this week by Astra Arcus

Nov. 9, 1998

Pfizer prepares metabolically stable adamantane derivatives

Nov. 9, 1998

Kyowa Hakko patents new adenosine A2A antagonists

Nov. 9, 1998

Pyrazolopyrimidines useful as analgesics prepared at Otsuka

Nov. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...